One year B and D vitamins supplementation improves metabolic bone markers

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 3, 2013, Pages 639-647

  Herrmann, Wolfgang ^a   Kirsch, Susanne H ^a   Kruse, Vera ^a   Eckert, Rudolf ^b   Gräber, Stefan ^a   Geisel, Jürgen ^a   Obeid, Rima ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b Marienkrankenhaus   (Germany)

Author keywords

B vitamins; Bone alkaline phosphatase; Deoxypyridoniline; Homocysteine; Osteocalcin; Osteoporosis; Parathormone; Sclerostin; Tartrate resistant acid phosphatase; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ADENOSYLHOMOCYSTEINASE; ALKALINE PHOSPHATASE BONE ISOENZYME; CALCIUM CARBONATE; COLECALCIFEROL; CYANOCOBALAMIN; FOLIC ACID; OSTEOCALCIN; PARATHYROID HORMONE; PYRIDOXINE; S ADENOSYLMETHIONINE; SCLEROSTIN;

ADULT; AGED; BLOOD SAMPLING; BONE METABOLISM; BONE TURNOVER; CONFERENCE PAPER; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; OSSIFICATION; OSTEOCYTE; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ACID PHOSPHATASE; AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE AND BONES; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; OSTEOPOROSIS; PARATHYROID HORMONE; S-ADENOSYLHOMOCYSTEINE; S-ADENOSYLMETHIONINE; VITAMIN B COMPLEX; VITAMIN D;

EID: 84882333088     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2012-0599     Document Type: Conference Paper

References (54)

1. Herrmann M, Duque G. Vitamin D and bone health. In: Herrmann W, Obeid R, editors. Vitamins in the prevention of human diseases, 1st ed. Berlin/New York: Walter de Gruyter, 2011:429-55.
2. Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet 2002;359:1761-7.
3. Suda T, Ueno Y, Fujii K, Shinki T. Vitamin D and bone. J Cell Biochem 2003;88:259-66.
4. Barnes MS, Robson PJ, Bonham MP, Strain JJ, Wallace JM. Effect of vitamin D supplementation on vitamin D status and bone turnover markers in young adults. Eur J Clin Nutr 2006;60:727-33.
5. Hutchison FN, Bell NH. Osteomalacia and rickets. Semin Nephrol 1992;12:127-45.
6. Grant WB. Solar ultraviolet irradiance and cancer incidence and mortality. Adv Exp Med Biol 2008;624:16-30.
7. Reichrath J. Using vitamin D for management of human diseases. In: Herrmann W, Obeid R, editors. Vitamins in the prevention of human diseases, 1st ed. Berlin/New York: Walter de Gruyter, 2011:399-409.
8. Zittermann A. Potential health effects of vitamin D. In: Herrmann W, Obeid R, editors. Vitamins in the prevention of human diseases, 1st ed. Berlin/New York: Walter de Gruyter, 2011:380-95.
9. Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81.
10. Gordon CM, De Peter KC, Feldman HA, Grace E, Emans SJ. Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med 2004;158:531-7.
11. Sullivan SS, Kushida CA. Multiple sleep latency test and maintenance of wakefulness test. Chest 2008;134:854-61.
12. Herrmann M, Peter SJ, Umanskaya N, Wagner A, Taban-Shomal O, Widmann T, et al. The role of hyperhomocysteinemia as well as folate, vitamin B (6) and B (12) deficiencies in osteoporosis: a systematic review. Clin Chem Lab Med 2007;45:1621-32.
13. Herrmann W. The importance of hyperhomocysteinemia as a risk factor for diseases: an overview. Clin Chem Lab Med 2001;39:666-74.
14. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999;69:842-56.
15. Lips P, Wiersinga A, Van Ginkel FC, Jongen MJ, Netelenbos JC, Hackeng WH, et al. The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. J Clin Endocrinol Metab 1988;67:644-50.
16. Bates CJ, Carter GD, Mishra GD, O'Shea D, Jones J, Prentice A. In a population study, can parathyroid hormone aid the definition of adequate vitamin D status? A study of people aged 65 years and over from the British National Diet and Nutrition Survey. Osteoporos Int 2003;14:152-9.
17. Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med 2004;116:634-9.
18. Cauley JA, Lacroix AZ, Wu L, Horwitz M, Danielson ME, Bauer DC, et al. Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med 2008;149:242-50.
19. Looker AC, Mussolino ME. Serum 25-hydroxyvitamin D and hip fracture risk in older U. S. white adults. J Bone Miner Res 2008;23:143-50.
20. Lips P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001;22:477-501.
21. Bjorkman M, Sorva A, Risteli J, Tilvis R. Vitamin D supplementation has minor effects on parathyroid hormone and bone turnover markers in vitamin D-deficient bedridden older patients. Age Ageing 2008;37:25-31.
22. Dhonukshe-Rutten RA, Pluijm SM, De Groot LC, Lips P, Smit JH, Van Staveren WA. Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. J Bone Miner Res 2005;20:921-9.
23. McLean RR, Jacques PF, Selhub J, Tucker KL, Samelson EJ, Broe KE, et al. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 2004;350:2042-9.
24. Herrmann M, Kraenzlin M, Pape G, Sand-Hill M, Herrmann W. Relation between homocysteine and biochemical bone turnover markers and bone mineral density in peri-and post-menopausal women. Clin Chem Lab Med 2005;43:1118-23.
25. Van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, Van Der Klift M, De Jonge R, Lindemans J, et al. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 2004;350:2033-41.
26. Herrmann M, Schmidt J, Umanskaya N, Colaianni G, Al-Marrawi F, Widmann T, et al. Stimulation of osteoclast activity by low B-vitamin concentrations. Bone 2007;41:584-91.
27. Herrmann M, Umanskaya N, Wildemann B, Colaianni G, Widmann T, Zallone A, et al. Stimulation of osteoblast activity by homocysteine. J Cell Mol Med 2008;12:1205-10.
28. Ozdem S, Samanci S, Tasatargil A, Yildiz A, Sadan G, Donmez L, et al. Experimental hyperhomocysteinemia disturbs bone metabolism in rats. Scand J Clin Lab Invest 2007;67:748-56.
29. Herrmann W, Obeid R, Schorr H, Hubner U, Geisel J, Sand-Hill M, et al. Enhanced bone metabolism in vegetarians - the role of vitamin B12 deficiency. Clin Chem Lab Med 2009;47:1381-7.
30. Carmel R, Lau KH, Baylink DJ, Saxena S, Singer FR. Cobalamin and osteoblast-specific proteins. N Engl J Med 1988;319:70-5.
31. Holstein JH, Herrmann M, Splett C, Herrmann W, Garcia P, Histing T, et al. High bone concentrations of homocysteine are associated with altered bone morphology in humans. Br J Nutr 2011;106:378-82.
32. Herrmann M, Tami A, Wildemann B, Wolny M, Wagner A, Schorr H, et al. Hyperhomocysteinemia induces a tissue specific accumulation of homocysteine in bone by collagen binding and adversely affects bone. Bone 2009;44:467-75.
33. Goerss JB, Kim CH, Atkinson EJ, Eastell R, O'Fallon WM, Melton LJ, III. Risk of fractures in patients with pernicious anemia. J Bone Miner Res 1992;7:573-9.
34. Appleby P, Roddam A, Allen N, Key T. Comparative fracture risk in vegetarians and nonvegetarians in EPIC-Oxford. Eur J Clin Nutr 2007;61:1400-6.
35. Dhonukshe-Rutten RA, Van Dusseldorp M, Schneede J, De Groot LC, Van Staveren WA. Low bone mineral density and bone mineral content are associated with low cobalamin status in adolescents. Eur J Nutr 2005;44:341-7.
36. Wang YF, Chiu JS, Chuang MH, Chiu JE, Lin CL. Bone mineral density of vegetarian and non-vegetarian adults in Taiwan. Asia Pac J Clin Nutr 2008;17:101-6.
37. Stabler SP, Lindenbaum J, Savage DG, Allen RH. Elevation of serum cystathionine levels in patients with cobalamin and folate deficiency. Blood 1993;81:3404-13.
38. Kirsch SH, Knapp JP, Geisel J, Herrmann W, Obeid R. Simultaneous quantification of S-adenosyl methionine and S-adenosyl homocysteine in human plasma by stable-isotope dilution ultra performance liquid chromatography tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877:3865-70.
39. Kirsch SH, Knapp JP, Herrmann W, Obeid R. Quantification of key folate forms in serum using stable-isotope dilution ultra performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2010;878:68-75.
40. Need AG. Bone resorption markers in vitamin D insufficiency. Clin Chim Acta 2006;368:48-52.
41. Bischoff-Ferrari H, Stahelin HB, Walter P. Vitamin D effects on bone and muscle. Int J Vitam Nutr Res 2011;81:264-72.
42. Moester MJ, Papapoulos SE, Lowik CW, Van Bezooijen RL. Sclerostin: current knowledge and future perspectives. Calcif Tissue Int 2010;87:99-107.
43. Mirza FS, Padhi ID, Raisz LG, Lorenzo JA. Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women. J Clin Endocrinol Metab 2010;95:1991-7.
44. Piemonte S, Romagnoli E, Bratengeier C, Woloszczuk W, Tancredi A, Pepe J, et al. Serum sclerostin levels decline in postmenopausal women with osteoporosis following treatment with intermittent PTH. J Endocrinol Invest 2012; DOI:10.3275/8522.
45. Gatti D, Viapiana O, Fracassi E, Idolazzi L, Dartizio C, Povino MR, et al. Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. J Bone Miner Res 2012;27:2259-63.
46. Ooms ME, Roos JC, Bezemer PD, Van Der Vijgh WJ, Bouter LM, Lips P. Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab 1995;80:1052-8.
47. Prestwood KM, Pannullo AM, Kenny AM, Pilbeam CC, Raisz LG. The effect of a short course of calcium and vitamin D on bone turnover in older women. Osteoporos Int 1996;6:314-9.
48. Ambroszkiewicz J, Klemarczyk W, Gajewska J, Chelchowska M, Strucinska M, Oltarzewski M, et al. [Effect of vitamin D supplementation on serum 25-hydroxyvitamin D and bone turnover markers concentrations in vegetarian children]. Med Wieku Rozwoj 2009;13:34-9.
49. Herrmann M, Widmann T, Colaianni G, Colucci S, Zallone A, Herrmann W. Increased osteoclast activity in the presence of increased homocysteine concentrations. Clin Chem 2005;51:2348-53.
50. Herrmann M, Wildemann B, Claes L, Klohs S, Ohnmacht M, Taban-Shomal O, et al. Experimental hyperhomocysteinemia reduces bone quality in rats. Clin Chem 2007;53:1455-61.
51. Herrmann M, Umanskaya N, Traber L, Schmidt-Gayk H, Menke W, Lanzer G, et al. The effect of B-vitamins on biochemical bone turnover markers and bone mineral density in osteoporotic patients: a 1-year double blind placebo controlled trial. Clin Chem Lab Med 2007;45:1785-92.
52. Green TJ, McMahon JA, Skeaff CM, Williams SM, Whiting SJ. Lowering homocysteine with B vitamins has no effect on biomarkers of bone turnover in older persons: a 2-y randomized controlled trial. Am J Clin Nutr 2007;85:460-4.
53. Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. J Am Med Assoc 2005;293:1082-8.
54. Saito M, Fujii K, Marumo K. Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls. Calcif Tissue Int 2006;79:160-8.